Consider the Role of Mounjaro for Type 2 Diabetes
You’ll hear buzz about new injectable Mounjaro (tirzepatide)...the first “twincretin” for type 2 diabetes.
Think of Mounjaro as similar to a glucagon-like peptide-1 (GLP-1) agonist...but it’s also a glucose-dependent insulinotropic polypeptide (GIP) agonist. More twincretins are in the works.
GLP-1 and GIP stimulate insulin release, increase satiety, and decrease glucose production.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote